Rowlandmiller & Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$336K |
| 2 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$228K |
| 3 |
Eli Lilly
LLY
|
+$174K |
| 4 |
Automatic Data Processing
ADP
|
+$163K |
| 5 |
Abercrombie & Fitch
ANF
|
+$156K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$15.5M |
| 2 |
Walt Disney
DIS
|
+$708K |
| 3 |
JPMorgan Chase
JPM
|
+$316K |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$299K |
| 5 |
Chipotle Mexican Grill
CMG
|
+$234K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.45% |
| 2 | Healthcare | 15.36% |
| 3 | Financials | 13.43% |
| 4 | Consumer Staples | 13.2% |
| 5 | Consumer Discretionary | 10.28% |
Similar funds
Rowlandmiller & Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Rowlandmiller & Partners held 153 positions worth $250M, down 15% from $295M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Rowlandmiller & Partners withdrew a net $16.2M in Q3 2020, closing 11 positions and reducing 43 holdings. Its most notable exit was Bio-Rad Laboratories Class A, an estimated $299K position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Rowlandmiller & Partners opened a new position in Abercrombie & Fitch worth $122K.
- Rowlandmiller & Partners's largest Q3 2020 buy was Abercrombie & Fitch: 13,395 shares worth $122K.
- Rowlandmiller & Partners added most to Microsoft in Q3 2020, an estimated $336K increase.
- Rowlandmiller & Partners's biggest Q3 2020 reduction was Apple, cutting an estimated $15.5M.
- Rowlandmiller & Partners fully exited Bio-Rad Laboratories Class A in Q3 2020, selling an estimated $299K.
- Rowlandmiller & Partners's ten largest holdings make up 40% of its $250M portfolio in Q3 2020.
- Rowlandmiller & Partners opened 3 new positions and closed 11 in Q3 2020.
- Rowlandmiller & Partners's portfolio value fell 15% quarter-over-quarter to $250M.
Based on Rowlandmiller & Partners's 13F filing for Q3 2020, filed 12 Nov 2020.